title: Mechanisms of tolerance to the anticonvulsant effects of acetazolamide in mice: relation to the activity and amount of carbonic anhydrase in brain.
abstract: The mechanism by which tolerance develops to the anticonvulsant effects of acetazolamide (AZM) was investigated in Swiss-Webster mice. The effects of single and six daily doses of 40 mg or 200 mg/kg AZM on electroshock seizure threshold (EST), maximal electroshock (MES) seizure pattern, and on the activity and total amount of carbonic anhydrase II (CAII) in various subcellular fractions (cytosol, microsomes, and myelin) of cerebral cortex, cerebellum, and brainstem were assessed. The activity of CAII was measured by microassay, and the total amount was measured by immunoassay methods developed in this laboratory. From the activity (units per microgram of protein) and total amount (nanograms per microgram protein) data, the specific activity (units per nanogram CAII) of the enzyme was calculated. With multiple doses, tolerance developed to both elevation of the EST and modification of the MES pattern noted with single doses of AZM. Accompanying the development of tolerance to the anticonvulsant effects of AZM was an increase in both the activity and specific activity of CAII in the various subcellular fractions and areas of the brain. The effects were dose dependent. Tolerance to the EST-elevating effects of AZM correlated with increases in the activity, total amount, and specific activity of CAII in the myelin fraction of the cerebral cortex.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Physiology, University of Utah School of Medicine, Salt Lake City 84108.
authors.forename: R E
authors.initials: RE
authors.lastname: Anderson
authors.forename: P
authors.initials: P
authors.lastname: Chiu
authors.forename: D M
authors.initials: DM
authors.lastname: Woodbury
mesh_terms: D000086:Acetazolamide / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D000927:Anticonvulsants / Q000008:administration & dosage / Q000494:pharmacology*; D001921:Brain / Q000201:enzymology*; D002256:Carbonic Anhydrases / Q000032:analysis* / Q000378:metabolism; D004361:Drug Tolerance; D004597:Electroshock; D007118:Immunoassay; D051379:Mice; D012640:Seizures / Q000201:enzymology / Q000503:physiopathology
chemical_list: D000927:Anticonvulsants; D002256:Carbonic Anhydrases; D000086:Acetazolamide